ArtJen Announces Updated Web Site for Their Fat Fighter

Share Article

ArtJen Complexus Holdings Corp. is pleased to announce that as part of its continuing effort to make its Fat Fighter, FBCx, more readily available, it has updated and improved its website to include News on Obesity. The updated user friendly page allows visitors to quickly and easily scan the currents news and reports on obesity.

Dubbed the “Fat Fighter” in recent coverage by the Detroit Fox Network affiliate and said to be showing “huge potential” by Canadian print media, ArtJen Complexus Holdings Corp. is pleased to announce that as part of its continuing effort to make our Fat Fighter, FBCx, more readily available it has updated and improved its website http://www.artjen.net to include a page devoted solely to News on Obesity. From its conception ArtJen’s site was meant to be educational, now visitors can keep abreast of the current developments and news on the obesity epidemic by simply clicking the regularly updated links at http://www.artjen.net/obesity_news.html.

Dr. Joseph Artiss, VP ArtJen, says that, “We want you to come to our website to purchase FBCx, but much more importantly we want you to leave our site knowing a little more about obesity and weight loss than when you came.”

FBCx, the most promising weapon in the war on obesity is available in all SAV-ON Drug stores in Southeastern Michigan as well as Dr. Grunberger’s Diabetes Institute in Bloomfield Hills, MI (248-335-7740). A complete list of both US and Canadian FBCx retailers can be found at: http://www.artjen.net/shopinperson.html.

George Grunberger, M.D., K-L Catherine Jen, Ph.D. and Joseph Artiss, Ph.D. recently presented the findings of their clinical trial on volunteers with type 2 diabetes at both the June meeting of the American Diabetes Association and the October meeting of the North American Association for the Study of Obesity. Impressive results from the double-blind, placebo controlled clinical trial include:

  • FBCx is effective in reducing and/or maintaining body weight in patients with type 2 diabetes.
  • FBCx is effective in reducing blood cholesterol and triglyceride levels in patients with elevated lipids.
  • FBCx can easily be incorporated into anybody’s weight management regimen.
  • FBCx was shown to bind 9 times its own weight in dietary fat in human volunteers.
  • FBCx is effective for weight management.

Dr Grunberger, of the renowned Grunberger Diabetes Institute states that: “About 90 % of patients with type 2 diabetes are obese and that obesity is the number 2 preventable cause of death in the U.S.” Before FBCx, “There was no known effective way to keep weight off.” Dr Grunberger continued, “This discovery, which can help shed pounds or prevent weight gain, is real progress.” Dr Jen was quoted as saying that, “If FBCx works for obese diabetics it will work for anybody.”

The important results of this clinical trial could change dietary management in patients with type 2 diabetes. Subjects in preclinical trials, including non-diabetic patients showed dramatic and consistent weight loss. Employing a natural fiber, each 1 gram tablet binds 9 grams of dietary fat, effectively preventing the fat from being absorbed by the body.

By taking the recommended 2 tablets per typical North American meal results in a weight loss of 4 to 6 pounds per month. The product is now available under the FBCx trademark. A US patent has been awarded to the ArtJen Company for FBCx; worldwide patents are pending.

For further information contact Dr. Joe Artiss through ArtJen’s toll free number 1-877-4-ARTJEN.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joseph Artiss